CC
BIIB icon

Centiva Capital’s Biogen BIIB Stock Holding History

Centiva Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-250,000
Closed -$44M – 1690
2025
Q4 		$44M Hold
250,000
– – 0.36% 58
2025
Q3 		$35M Buy
+250,000
New +$33.8M 0.33% 54
2023
Q4 		– Sell
-4,100
Closed -$1.05M – 1811
2023
Q3 		$1.05M Buy
+4,100
New +$1.1M 0.02% 612
2023
Q1 		– Sell
-3,100
Closed -$858K – 1525
2022
Q4 		$858K Sell
3,100
-2,500
-45% -$706K 0.02% 614
2022
Q3 		$1.5M Sell
5,600
-7,100
-56% -$1.51M 0.03% 456
2022
Q2 		$2.59M Sell
12,700
-13,700
-52% -$2.8M 0.06% 289
2022
Q1 		$5.56M Buy
26,400
+15,500
+142% +$3.37M 0.11% 151
2021
Q4 		$2.62M Buy
+10,900
New +$2.8M 0.05% 303
2020
Q2 		– Sell
-10,200
Closed -$3.23M – 674
2020
Q1 		$3.23M Buy
10,200
+2,000
+24% +$607K 0.14% 98
2019
Q4 		$2.43M Buy
8,200
+5,200
+173% +$1.44M 0.12% 168
2019
Q3 		$698K Hold
3,000
– – 0.04% 256
2019
Q2 		$702K Sell
3,000
-1,000
-25% -$231K 0.04% 236
2019
Q1 		$945K Sell
4,000
-3,500
-47% -$1.1M 0.06% 183
2018
Q4 		$2.26M Buy
7,500
+4,100
+121% +$1.31M 0.18% 85
2018
Q3 		$1.2M Hold
3,400
– – 0.1% 96
2018
Q2 		$986K Buy
+3,400
New +$956K 0.21% 40

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Centiva Capital's BIIB Position: Q1 2025 in Review

Centiva Capital sold out of Biogen (BIIB) in Q1 2025, closing a stake of 1,858 shares — an estimated $284K sold.

Centiva Capital first reported a position in BIIB in Q1 2019 and held it in 19 quarters. The position peaked at $5.26M in Q1 2022. 882 funds tracked by Wall St. Rank hold BIIB as of Q1 2025.

  • Centiva Capital reported no remaining Biogen position as of Q1 2025 after selling out during the quarter.
  • Centiva Capital sold 1,858 Biogen shares in Q1 2025, an estimated $284K.
  • Centiva Capital first reported a position in Biogen in Q1 2019 and held it in 19 quarters.
  • Centiva Capital's Biogen position peaked at $5.26M in Q1 2022.
  • 882 funds tracked by Wall St. Rank held Biogen as of Q1 2025.

Based on Centiva Capital's 13F filing for Q1 2025, filed 15 May 2025.